INKT
MiNK Therapeutics, Inc. · Healthcare · Market cap $55.1M
Insiders sold $73K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Oct 14, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$120K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Oct 14, 2026
Buell Jennifer
MiNK Therapeutics, Inc. (INKT) has 22 SEC Form 4 filings (33 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Oct 14, 2026.
Inside the rolling window, 2 insiders at MiNK Therapeutics, Inc. reported no open-market purchases and 6 open-market sales totaling $120K. The most active filer is Director Ryan Barbara with 5 filings. The most recent open-market filing is a sale of 6,938 shares by Chief Executive Officer Buell Jennifer, dated Oct 12, 2026, worth $73K.
- Industry:Biotechnology
- CEO:Jennifer S. Buell
- Employees:15
- HQ:New York City, NY, US
- IPO:2021-10-15
Frequently asked questions
How many SEC Form 4 insider filings does INKT have?
MiNK Therapeutics, Inc. (INKT) has 22 SEC Form 4 filings (33 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Oct 14, 2026.
When was the most recent SEC Form 4 filing for INKT?
The most recent Form 4 filing for INKT on Tracefour is dated Oct 14, 2026.
Who is the most active insider at INKT?
The most active SEC Form 4 filer at INKT in the rolling window is Director Ryan Barbara, with 5 filings.
What is the net insider flow at INKT over the last 6 months?
Over the trailing 180 days, insiders at INKT have net sold $92K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at INKT in the current window?
Inside the rolling window, insiders at INKT bought $0 and sold $120K based on SEC Form 4 filings.
Can I get alerts for INKT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MiNK Therapeutics, Inc. (INKT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
MiNK Therapeutics, Inc. is in the Healthcare sector.